Rivulet Capital LLC Has $15.65 Million Holdings in Rxo Inc $RXO

Rivulet Capital LLC boosted its holdings in Rxo Inc (NYSE:RXO) by 32.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 995,750 shares of the company’s stock after purchasing an additional 245,750 shares during the quarter. RXO accounts for about 1.5% of Rivulet Capital LLC’s portfolio, making the stock its 14th largest holding. Rivulet Capital LLC owned approximately 0.61% of RXO worth $15,653,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in RXO. Wellington Management Group LLP increased its holdings in shares of RXO by 374.1% during the first quarter. Wellington Management Group LLP now owns 9,259,421 shares of the company’s stock worth $176,855,000 after purchasing an additional 7,306,537 shares during the period. T. Rowe Price Investment Management Inc. acquired a new stake in RXO during the first quarter worth approximately $56,693,000. Norges Bank acquired a new stake in RXO during the second quarter worth approximately $16,949,000. Marshall Wace LLP bought a new position in RXO during the 2nd quarter worth $7,124,000. Finally, Nuveen LLC acquired a new position in RXO in the 1st quarter valued at $8,107,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

Insider Buying and Selling

In related news, CEO Andrew M. Wilkerson bought 7,775 shares of RXO stock in a transaction that occurred on Monday, November 10th. The shares were acquired at an average cost of $12.88 per share, for a total transaction of $100,142.00. Following the completion of the acquisition, the chief executive officer directly owned 7,775 shares of the company’s stock, valued at approximately $100,142. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Troy A. Cooper bought 8,317 shares of the firm’s stock in a transaction on Thursday, November 20th. The shares were purchased at an average cost of $10.61 per share, with a total value of $88,243.37. Following the transaction, the director directly owned 275,416 shares in the company, valued at approximately $2,922,163.76. This trade represents a 3.11% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 40,250 shares of company stock valued at $488,875 over the last ninety days. 1.48% of the stock is owned by company insiders.

Analyst Ratings Changes

RXO has been the topic of several analyst reports. Benchmark reissued a “hold” rating on shares of RXO in a report on Wednesday, October 22nd. Stifel Nicolaus upped their price objective on shares of RXO from $14.00 to $17.00 and gave the stock a “hold” rating in a research report on Friday, October 10th. Susquehanna reduced their price objective on shares of RXO from $11.00 to $10.00 and set a “negative” rating on the stock in a research note on Friday, November 7th. Morgan Stanley raised shares of RXO from an “equal weight” rating to an “overweight” rating and set a $19.00 target price on the stock in a report on Tuesday, November 11th. Finally, Wall Street Zen lowered shares of RXO from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Four analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $16.69.

RXO Stock Performance

Shares of RXO stock opened at $14.43 on Monday. The stock has a market cap of $2.37 billion, a price-to-earnings ratio of -33.55 and a beta of 1.74. Rxo Inc has a twelve month low of $10.43 and a twelve month high of $29.60. The company’s fifty day moving average is $15.05 and its 200 day moving average is $15.68. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.24.

RXO (NYSE:RXO) last announced its earnings results on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.02). RXO had a positive return on equity of 0.88% and a negative net margin of 1.25%.The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same period in the previous year, the firm posted $0.05 earnings per share. The firm’s quarterly revenue was up 34.6% compared to the same quarter last year. Sell-side analysts forecast that Rxo Inc will post 0.31 EPS for the current year.

About RXO

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.